SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 70 filers reported holding SOLENO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -16.7% | 105,481 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | -44.2% | 105,481 | 0.0% | 0.00% | – |
| Q4 2021 | $43,000 | -55.7% | 105,481 | 0.0% | 0.00% | – |
| Q3 2021 | $97,000 | -19.2% | 105,481 | 0.0% | 0.00% | – |
| Q2 2021 | $120,000 | -84.3% | 105,481 | -82.6% | 0.00% | – |
| Q1 2021 | $763,000 | -40.9% | 605,362 | -9.6% | 0.00% | – |
| Q4 2020 | $1,292,000 | -18.0% | 669,610 | +6.7% | 0.00% | – |
| Q3 2020 | $1,575,000 | +89.8% | 627,686 | +68.0% | 0.00% | – |
| Q2 2020 | $830,000 | +634.5% | 373,574 | +689.2% | 0.00% | – |
| Q1 2020 | $113,000 | +63.8% | 47,333 | +100.4% | 0.00% | – |
| Q4 2019 | $69,000 | +187.5% | 23,618 | +103.1% | 0.00% | – |
| Q1 2019 | $24,000 | +20.0% | 11,630 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | -20.0% | 11,630 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | -7.4% | 11,630 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | – | 11,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $22,769,000 | 6.37% |
| CVI Holdings, LLC | 1,550,960 | $3,443,000 | 1.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,670,384 | $8,148,000 | 1.03% |
| Trellus Management Company, LLC | 366,432 | $813,000 | 0.88% |
| AWM Investment Company, Inc. | 1,550,000 | $3,441,000 | 0.60% |
| Samsara BioCapital, LLC | 750,000 | $1,665,000 | 0.54% |
| Nantahala Capital Management | 7,426,368 | $16,487,000 | 0.50% |
| Consonance Capital Management LP | 3,040,000 | $6,749,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,233,676 | $2,739,000 | 0.26% |
| Granite Point Capital Management, L.P. | 2,200,000 | $4,884,000 | 0.25% |